1. ScholarBank@NUS

Seng Gee Lim

rp00481

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Seng Gee Lim
Variants
Lee Lim, S.G.
Lim, S.G.
Seng, Foreword Gee Lim
Seng, G.L.
Lim Seng Gee
Lim, Seng Gee
Lim, S.-G.
 
Main Affiliation
 
Faculty
 
Email
mdclimsg@nus.edu.sg
 

Publications

Results 1-20 of 160 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
120082-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesisZubaidah, R.M. ; Chung, M.C.M. ; Gek, S.T.; Tan, S.B.E.; Lin, Q. ; Seng, G.L. 
220082-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesisZubaidah, R.M. ; Chung, M.C.M. ; Gek, S.T.; Tan, S.B.E. ; Lin, Q. ; Seng, G.L. 
325-Mar-2020A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaKong, Li Ren ; Salleh, Nur Afiqah Binte Mohamed ; Ong, Richard Weijie; Tan, Tuan Zea ; Syn, Nicholas L; Goh, Robby Miguel; Fhu, Chee Wei ; Tan, Daniel SW ; Iyer, N Gopalakrishna ; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Yaw Chyn ; Soo, Ross ; Ho, Jingshan ; Huang, Yiqing; Lim, Joline SJ ; Yan, Benedict Junrong; Nga, Min En ; Lim, Seng Gee ; Koeffler, H Phillip ; Lee, Soo Chin ; Kappei, Dennis ; Hung, Huynh The ; Goh, Boon Cher 
42006A double-blind placebo-controlled study of emtricitabine in chronic hepatitis BLim, S.G. ; Ng, T.M.; Guan, R.; Kung, N.; Krastev, Z.; Volfova, M.; Husa, P.; Lee, S.S.; Chan, S.; Shiffman, M.L.; Washington, M.K.; Rigney, A.; Anderson, J.; Mondou, E.; Snow, A.; Sorbel, J.; Rousseau, F.
52010A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis BTan, A.T.; Koh, S.; Goh, W.; Gehring, A.J.; Bertoletti, A. ; Lim, S.G. ; Zhe, H.Y.
6Jun-2008A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)Lee, Y.-M. ; Sutedja, D.S.; Wai, C.-T. ; Dan, Y.-Y. ; Aung, M.-O. ; Zhou, L. ; Cheng, C.-L.; Wee, A.; Lim, S.-G. 
72006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E.; Bowden, S.; Locarnini, S.; Ishaque, S.M.
82006A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis BLim, S.G. ; Wai, C.-T. ; Lee, Y.M. ; Dan, Y.Y.; Sutedja, D.S.; Wee, A. ; Suresh, S.; Wu, Y.J.; Machin, D.; Lim, C.C.; Fock, K.M.; Koay, E. ; Bowden, S.; Locarnini, S.; Ishaque, S.M.
91-Oct-2017Acute-on-chronic liver failure in a multi-ethnic Asian city: A comparison of patients identified by Asia-Pacific Association for the Study of the Liver and European Association for the Study of the Liver definitionsRajoo, AS; Lim, SG ; Phyo, WW ; Tun, T; Dan, YY ; Lee, YM ; Low, HC ; Lim, K; Tan, PS; Lee, GH 
102004Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplantWai, C.-T.; Prabhakaran, K. ; Wee, A. ; Lee, Y.-M.; Dan, Y.-Y.; Sutedja, D.S.; Mak, K.; Isaac, J. ; Lee, K.-H. ; Lee, H.-L.; Da, Costa M. ; Lim, S.-G. 
112003Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis BHadziyannis, S.J.; Tassopoulos, N.C.; Heathcote, E.J.; Chang, T.-T.; Kitis, G.; Rizzetto, M.; Marcellin, P.; Lim, S.G. ; Goodman, Z.; Wulfsohn, M.S.; Xiong, S.; Fry, J.; Brosgart, C.L.
122003Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis BMarcellin, P.; Chang, T.-T.; Lim, S.G. ; Tong, M.J.; Sievert, W.; Shiffman, M.L.; Jeffers, L.; Goodman, Z.; Wulfsohn, M.S.; Xiong, S.; Fry, J.; Brosgart, C.L.
13Aug-2007Age in Guiding Strategy in Hepatitis A VaccinationWai, C.-T. ; Mak, B.; Aung, M.O. ; Lim, S.-G. 
142003An anti-HIV-1 gp120 antibody expressed as an endocytotic transmembrane protein mediates internalization of HIV-1Tan, Y.-J.; Lim, S.-P.; Ting, A.E.; Goh, P.-Y.; Tan, Y.H.; Lim, S.G. ; Hong, W.
15Apr-2012APASL consensus statements and management algorithms for hepatitis C virus infectionOmata, M.; Kanda, T.; Yu, M.-L.; Yokosuka, O.; Lim, S.-G. ; Jafri, W.; Tateishi, R.; Hamid, S.S.; Chuang, W.-L.; Chutaputti, A.; Wei, L.; Sollano, J.; Sarin, S.K.; Kao, J.-H.; McCaughan, G.W.
162007Applicability of cost-effectiveness analysis to management of chronic hepatitis BDan, Y.Y.; Lim, S.G. 
172006Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?Cheng, Y. ; Seet, B.L.; Ong, C.S.L.; Wasser, S. ; Lim, S.G. ; Tan, T.M.C. ; Peter, F.J. 
182010Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaOmata, M.; Tateishi, R.; Yoshida, H.; Shiina, S.; Lesmana, L.A.; Budihusodo, U.; Lesmana, C.R.; Chen, P.-J.; Lin, S.-M.; Liaw, Y.F.; Kudo, M.; Lee, J.M.; Choi, B.I.; Poon, R.T.P.; Cheng, A.L.; Jia, J.-D.; Obi, S.; Han, K.H.; Jafri, W.; Chow, P.; Lim, S.G. ; Chawla, Y.K.; Gani, R.A.; Putranto, T.A.; Sarin, S.K.
192014BAsE-Seq: a method for obtaining long viral haplotypes from short sequence readsHong, L.Z.; Hong, S.; Wong, H.T.; Aw, P.P.; Cheng, Y.; Wilm, A.; de Sessions, P.F.; Lim, S.G. ; Nagarajan, N. ; Hibberd, M.L. ; Quake, S.R.; Burkholder, W.F.
20Jul-2009Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BZeuzem, S.; Gane, E.; Liaw, Y.-F.; Lim, S.G. ; DiBisceglie, A.; Buti, M.; Chutaputti, A.; Rasenack, J.; Hou, J.; O'Brien, C.; Nguyen, T.T.; Jia, J.; Poynard, T.; Belanger, B.; Bao, W.; Naoumov, N.V.